Global Human Leukocyte Antigen Typing and Antibody Testing Market Growth (Status and Outlook) 2024-2030

Global Human Leukocyte Antigen Typing and Antibody Testing Market Growth (Status and Outlook) 2024-2030

Human leukocyte antigen (HLA), also known as transplantation antigen, is related to allogeneic tissue and organ transplantation and graft rejection. HLA tissue matching is one of the important factors affecting the survival rate of organ transplantation, hematopoietic stem cell transplantation and the quality of life of the recipient. HLA genes are highly polymorphic and determine the polymorphism of the expressed HLA antigen molecules. Currently, genotyping detection technology is mainly used for HLA typing. Compared with serological and cytological methods, it has higher sensitivity and accuracy and can detect more types.

The global Human Leukocyte Antigen Typing and Antibody Testing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Human Leukocyte Antigen Typing and Antibody Testing Industry Forecast” looks at past sales and reviews total world Human Leukocyte Antigen Typing and Antibody Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Leukocyte Antigen Typing and Antibody Testing sales for 2023 through 2029. With Human Leukocyte Antigen Typing and Antibody Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Leukocyte Antigen Typing and Antibody Testing industry.

This Insight Report provides a comprehensive analysis of the global Human Leukocyte Antigen Typing and Antibody Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Leukocyte Antigen Typing and Antibody Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Leukocyte Antigen Typing and Antibody Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Leukocyte Antigen Typing and Antibody Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Leukocyte Antigen Typing and Antibody Testing.

United States market for Human Leukocyte Antigen Typing and Antibody Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Human Leukocyte Antigen Typing and Antibody Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Human Leukocyte Antigen Typing and Antibody Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Human Leukocyte Antigen Typing and Antibody Testing players cover Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Leukocyte Antigen Typing and Antibody Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Antigen Typing
Antibody Testing

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Antigen Typing
Antibody Testing

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Siemens
Roche
Thermo Fisher Scientific
Immucor
CareDx
Natera
Eurofins Scientific
Medix Biochemica
GENDX
CGT Global
Beckman Coulter

Please note: The report will take approximately 2 business days to prepare and deliver.